Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using cytochemical methods the authors studied the activity of certain lysosomal enzymes and cytochrome oxidase in peripheral blood leucoytes in 22 patients with Wilson's disease. The control group comprised 50 healthy blood donors. It was found that the activity of acid phosphatase in the lymphocytes of patients was higher than in controls, the mean indices being respectively 90.50 +/- 8.95 and 60.38 +/- 3.95. The activity of beta-glucuronidase was found to be lower in the lymphocytes of patients, the mean value was 25.10 +/- 8.59 in patients and 64.91 +/- 5.78 in controls. The activity of cytochrome oxidase was lower in the granulocytes of patients with Wilson's disease than in controls, the mean values being 54.5 +/- 12.14 and 156 +/- 15.41 respectively. The activity of acid phosphatase in granulocytes as well as that of non-specific esterase in lymphocytes was similar in both groups. Decreased antigen degradation in Wilson's disease may be due not only to
liver cirrhosis
but also to disturbances in the metabolism of white blood cells, including, among others, decreased activity of cytochrome oxidase. The rise of the activity of acid phosphatase and reduced activity of beta-glucuronidase indicate chronic antigenic stimulation of lymphoid system.
Neurol Neurochir
Pol
PMID:[Cytochemical studies of peripheral white blood cells in Wilson's disease]. 19 62
In 11 patients with compensated and 10 with decompensated
liver cirrhosis
the following determinations were carried out: total thyroxine serum concentration (T4), triiodothyronine-binding coefficient (T3BC), free thyroxine by the dialysis method (DFT4), free thyroxine index (FT4I) and absolute value of free thyroxine (ADFT4). A statistically significant rise of T3BC, DFT4, ADFT4 and FT4I was observed only in the group of decompensated
cirrhosis
. It is supposed that these changes develop not as a result of excessive production of thyroid hormones but due to disturbances in the binding capacity of the proteins which bind thyroid hormones and also due to an impaired degradation of these hormones in the liver.
Pol
Med Sci Hist Bull
PMID:Total and free thyroxine in patients with liver cirrhosis. 82 99
In two cases of hepatic coma following advanced
liver cirrhosis
exchange transfusions were applied with plasmapheresis. In both cases the general condition of patients improved and consciousness returned. After exchange transfusions with plasmapheresis the serum levels of bilirubin, urea and ammonia decreased. Using appropriately selected fluids for erythrocyte suspension it is possible to affect selectively protein depletion and depletion of plasma blood clotting factors.
Pol
Med Sci Hist Bull
PMID:Exchange transfusion with plasmapheresis in the management of hepatic coma. 98 46
Post-mortem examinations concerned 16 pigs which had died of the oedema disease. A group of 8 healthy pigs were slaughtered at the Lublin abattoir and used as controls. All animals were subjected to detailed autopsy, and sections of the liver were taken for histological examination. The fixed material was cut into sections by the paraffin and refrigeration methods. To the routine staining with haematoxylin and eosin, colour reactions were added to reveal glycogen, simple fats and acid and alkaline phosphatase. The macro- and microscopic examinations demonstrated chronic, focal inflammation of the liver capsule connected with
liver cirrhosis
. Hyperaemia of the liver was noticed in all cases. A decrease of glycogen, associated with progressive fatty infiltration of the liver cells, was observed in the diseased pigs in contrast to the control group. An increase of the activity of hydrolytic enzymes and a positive reaction to cholesterol compounds are symptoms of progressive catabolic changes in the liver cells.
Pol
Arch Weter 1975
PMID:[Estimation of pathomorphological and histochemical changes in the liver of pigs in the course of edema disease of swine]. 118 54
Haemorrhage from oesophageal varices is one of the most common reason of death of patients with
liver cirrhosis
. The possibility of treatment and prevention of the haemorrhage by endoscopic sclerotherapy (ES) has become one of the achievements of contemporary medicine. Nevertheless there are some complications described after this procedure, the most severe being the pulmonary embolia. In our study we analyzed the pulmonary circulation by perfusion scintigraphy after ES. Among twelve patients treated by ES we found two cases of disturbed pulmonary perfusion. We did not find clinical or gasometric changes in these patients. We suggest there should be done pulmonary perfusion monitoring after ES.
Mater Med
Pol
PMID:Disturbances of the pulmonary perfusion after endoscopic sclerotherapy of oesophageal varices. 130 44
High-differentiated hepatocellular carcinoma (h-d HCC) is a not frequent hepatic tumour but its outcome may be beneficial when treated properly. Two cases of h-d HCC recognized on the basis of postoperative histopathology are reported. We have discussed the role of fine needle biopsy in distinguishing h-d HCC from liver adenoma, and we have attempted to outline the diagnostic approach in clinically silent hepatic tumours which are not associated with
cirrhosis
or elevated alfa-fetoprotein plasma level.
Pol
Arch Med Wewn
PMID:[Highly differentiated cancer or adenoma of the liver: diagnostic approach in highly differentiated epithelial tumors of the liver]. 132 1
The aim of the study was to test the clinical value of HBV DNA polymerase (DNAp) determination in patients with various forms of HBV infection, namely: acute hepatitis, chronic hepatitis,
cirrhosis
and healthy HBV carriers. The determination of DNAp was found to be particularly useful in patients with chronic HBV infection with active virus replication (HBeAg+) independent of histopathological changes.
Pol
Arch Med Wewn 1992 Jun
PMID:[Hepatitis B virus DNA polymerase activity in various clinical forms of HBV infection]. 140 93
Fourteen patients, including 6 with viral hepatitis B and 8 with
liver cirrhosis
were treated with plasmapheresis for hepatic coma. Altogether 29 plasmaphereses were carried out. Complete recovery was achieved in one patient with viral hepatitis B and in 3 patients with
liver cirrhosis
. Plasmapheresis should be performed in patients with severe lesions to the liver. Classification of patients to the treatment should include clinical examination, biochemical and enzymatic tests, and evaluation of liver reserve with isotope hepatography. In case of the acute poisoning with hepatotoxic agents indications to plasmapheresis should be evaluated from the toxicologic point of view.
Pol
Tyg Lek
PMID:[Plasmapheresis in the treatment of hepatic coma]. 143 25
Non-A, non-B hepatitis has been diagnosed in 12 blood donors in a plasmapheresis unit. The course of the disease has been symptomatic, accompanied by jaundice, fatigue, and nausea in 8 cases, and subclinical in the remaining 4 patients. Nine patients were followed-up to 2 years and only 2 patients liver biochemical tests were normalized permanently. The biopsies performed, a year after the acute phase of hepatitis period revealed chronic active disease in patients, chronic persistent hepatitis in 2 patients, acute hepatitis in one, and normal liver in one patient. Repeated liver biopsies, performed one year later, have basically shown similar lesions except one patient in whom chronic active hepatitis progressed to incipient
liver cirrhosis
. No symptoms of the disease have been usually noted in patients with chronic form of the disease, and liver function tests have occasionally been normal.
Pol
Tyg Lek
PMID:[Epidemic focus of non-A, non-B viral hepatitis in a plasmapheresis unit]. 143 24
This paper presents results of 3-18 year clinical observation of 48 patients with chronic active hepatitis HBsAg (+). 40 patients had suffered viral hepatitis for a period from 6 months to 3 years (avg. 1.5 year) before chronic active hepatitis manifested.
Cirrhosis
hepatis was a consequence of chronic active hepatitis in 52.1%, chronic active hepatitis in 45.8%, and chronic persistence in 2.1% of cases, during observation period. The average transition time from chronic active hepatitis to
cirrhosis
was 3 years. 48% of
cirrhosis
hepatis occurred within 2 years starting from recognition of chronic active hepatitis and 80% within 5 years. Most cases of
cirrhosis
were recorded if patients had been treated with penicillamine and prednisone (80% of cases), then with azathioprine and prednisone (48% of cases), while the least with ++non-immunosuppressive therapy (penicillamine, isoprinosine or "+hepatic protectors").
Pol
Arch Med Wewn 1992 Oct
PMID:[Long-term clinical observations of chronic active hepatitis HBsAg (+)]. 148 26
1
2
3
4
5
6
7
8
9
10
Next >>